{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:14:07Z","timestamp":1768432447231,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijrobp.2014.11.027","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T01:30:48Z","timestamp":1425259848000},"page":"730-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prostate Hypofractionated Radiation Therapy With Injection of Hyaluronic Acid: Acute Toxicities in a Phase 2 Study"],"prefix":"10.1016","volume":"91","author":[{"given":"Olivier","family":"Chapet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Decullier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Faix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Jalade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Fenoglietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"Udrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciprian","family":"Enachescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2014.11.027_bib1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(00)00442-9","article-title":"Is the \u03b1\/\u03b2 ratio of I.5 from Brenner & Hall a modeling artifact?","volume":"47","author":"King","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib5","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1088\/0031-9155\/49\/19\/003","article-title":"Comparison of in\u00a0vitro and in\u00a0vivo \u03b1\/\u03b2 ratios for prostate cancer","volume":"49","author":"Carlson","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0360-3016(04)01262-3","article-title":"New data on the value of \u03b1\/\u03b2 evidence mounts that it is low","volume":"60","author":"Chappell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 3","key":"10.1016\/j.ijrobp.2014.11.027_bib7","first-page":"S815","article-title":"Dose fractionation sensitivities of low\/middle\/high-risk prostate cancer deduced from seven international primary institutional datasets","volume":"75","author":"Miralbell","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2009.10.008","article-title":"Confirmation of a low \u03b1\/\u03b2 ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics","volume":"79","author":"Proust-Lima","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ijrobp.2010.12.040","article-title":"Later outcomes and alpha\/beta estimate from hypofractionated conformal radiotherapy versus standard fractionation for localized prostate cancer","volume":"82","author":"Leborgne","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib10","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2013.51.1972","article-title":"Randomized trial of hypofractionated external beam radiotherapy for prostate cancer","volume":"31","author":"Pollack","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2009.07.1691","article-title":"A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer","volume":"78","author":"Arcangeli","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijrobp.2007.02.034","article-title":"Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients","volume":"69","author":"Prada","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brachy.2008.11.010","article-title":"Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients","volume":"8","author":"Prada","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2012.11.027","article-title":"Prostate hypofractionated radiation therapy: Injection of hyaluronic acid to better preserve the rectal wall","volume":"86","author":"Chapet","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2013.10.039","article-title":"Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy","volume":"88","author":"Chapet","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib16","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1111\/j.1464-410X.2012.11373.x","article-title":"Application technique: Placement of a prostate rectum spacer in men undergoing prostate radiation therapy","volume":"110","author":"Hatiboglu","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.radonc.2011.09.005","article-title":"Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer","volume":"100","author":"Pinkawa","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00066-012-0172-6","article-title":"Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer","volume":"188","author":"Pinkawa","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijrobp.2012.12.019","article-title":"A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: Analysis of dosimetric outcomes","volume":"87","author":"Song","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ijrobp.2009.07.1679","article-title":"Effects of prostate-rectum separation on rectal dose from external beam radiotherapy","volume":"76","author":"Susil","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib21","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.ijrobp.2012.03.028","article-title":"Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylene glycol spacer: A treatment planning comparison study","volume":"84","author":"Weber","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib22","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.ijrobp.2011.02.034","article-title":"Human collagen injections to reduce rectal dose during radiotherapy","volume":"82","author":"Noyes","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.radonc.2013.01.007","article-title":"Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: Results of a virtual planning investigation based on the pre- and postimplant imaging data of an international multicenter study","volume":"106","author":"Melchert","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.radonc.2012.11.009","article-title":"Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: Results of a multi-institutional phase II trial","volume":"106","author":"Uhl","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0090-4295(92)90279-6","article-title":"Anterior rectal wall haematoma: Complication of transrectal ultrasound-guided biopsy of prostate","volume":"39","author":"Seymour","year":"1992","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib26","first-page":"29","article-title":"Hematoma into peritoneum following transrectal echo-guided prostate biopsy inducing lower abdominal and urinary tract symptoms","volume":"78","author":"Bertaccini","year":"2006","journal-title":"Arch Ital Urol Andol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.pcan.4500548","article-title":"Acute periprostatic haematoma following a transrectal ultrasound-guided needle biopsy of the prostate","volume":"5","author":"Saad","year":"2002","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02551343","article-title":"Two cases of retrovesical haematoma following prostatic biopsy","volume":"29","author":"Sa\u00e7ak","year":"1997","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/BF02550727","article-title":"Pelvic haematoma following trucut biopsy of the prostate","volume":"28","author":"Anjum","year":"1996","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.urolonc.2009.10.004","article-title":"Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: Nonrandomized comparison with conventional fractionation","volume":"29","author":"Jereczek-Fossa","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib31","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1748-717X-2-29","article-title":"Hypofractionated intensity modulated irradiation for localized prostate cancer: Results from a phase I\/II feasibility study","volume":"2","author":"Junius","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2011.01.024","article-title":"Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy","volume":"81","author":"Vesprini","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib34","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2008.10.087","article-title":"Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: A nonrandomized contemporary comparison","volume":"74","author":"Leborgne","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2008.09.032","article-title":"Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: Analysis of toxicity","volume":"74","author":"Coote","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijrobp.2007.09.004","article-title":"Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer","volume":"71","author":"Yassa","year":"2008","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.04.049","article-title":"Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma","volume":"69","author":"Martin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.radonc.2011.12.020","article-title":"Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4Gy per fraction","volume":"103","author":"Wu","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib39","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2010.04.054","article-title":"Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer","volume":"80","author":"Lock","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib40","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/j.1464-410X.2010.09418.x","article-title":"Late morbidity and oncological outcome after radical hypofractionated radiothrapy in men with prostate cancer","volume":"106","author":"Di Staso","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2014.11.027_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.radonc.2006.06.005","article-title":"Phase II of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicity","volume":"80","author":"Soete","year":"2006","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614044368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614044368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T15:23:59Z","timestamp":1537802639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614044368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0360301614044368"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.11.027","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Hypofractionated Radiation Therapy With Injection of Hyaluronic Acid: Acute Toxicities in a Phase 2 Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}